December 14th 2017, the MAPS nonprofit fund recieve 59.89 BTC ($1 million) from an anonymous philanthropic donor associated with the Pinapple Fund ( www.pineapplefund.org ). This was part of around $86 million they planed to donate to a number of different charities. This will serve as funding for MAPS phase 3 clinical trials for MDMA psychotherapy for PTSD.
"MAPS estimates that Phase 3 clinical trials will cost $26 million. With $17.3 million already raised or pledged, MAPS still needs $8.7 million to make MDMA-assisted psychotherapy legally available to millions of people suffering with PTSD."
Others in the cryptocurrency market have donated to the sum of $120,000 in BTC, ETH, and LTC (Of which MAPS accepts all three openly)
"Founded in 1986, MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. Since its founding, MAPS has raised over $45.5 million for psychedelic therapy and medical marijuana research and education. For more information, visit maps.org."
Current topics of MAPS include MDMA for PTSD (as above), Ibogaine for hard drug addiction treatment, Magic Mushrooms for Cluster Headaches and a variety of other psychedelics for use in relief of anxiety, depression and to come to terms with tramatic life experiences.